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Staphylococcus hominis plays a vital role in causing pathogenic infections in marine animals. In recent years, natural 
compounds from marine resources have gained interest owing to their potential effect against multidrug-resistant bacteria. LuxS 
gene is an important virulence factor needed to coordinate the biofilm production but no structural information is available for 
LuxS protein. To identify the homology model and to validate LuxS protein structure, an investigation was carried out using 
Modeller software. Molecular dynamics analysis was performed using a Desmond protocol. Molecular docking studies were 
carried out using marine compounds to suppress the LuxS protein, and antibiotics were also docked. Virtual screening was 
performed with LuxS protein against binding (CID-11446) dock score (-9.647) and Maybridge databases (CID-9017) docking 
score (-9.820) to find the potential compounds which provide better results than marine compounds. On the basis of the 
findings, it is concluded that the marine compound Aerobactin (CID-123762) is a potential inhibitor for LuxS protein in S. 
hominis with the highest dock score of -10.337, having eight hydrogen bonding interactions. Hence the compound could be 
further exploited for producing a drug against S. hominis. 
[Keywords: Staphylococcus hominis; LuxS; Biofilm; Aerobactin; Maybridge database] 
Introduction 
The LuxS QS system is present in a variety of Gram-
negative and Gram-positive bacteria. In several 
pathogens it is involved in virulence, but it appears to be 
nonfunctional or not involved in virulence in some 
others1. The biochemical function of the LuxS protein of 
Staphylococcus aureus in producing AI-2 autoinducer 
has been demonstrated earlier2. The LuxS mutant strain 
formed a thicker and more compact biofilm compared to 
the wild-type strain and was a more successful colonizer 
in an animal model of central venous catheter infection. 
Sequence analysis of completed genomes revealed that 
Staphylococcus spp., like many other bacteria, also 
contain a LuxS gene and therefore may employ a second 
signaling system based on the furan one derivative, 
autoinducer 2 (AI-2).3 The genome of a wide variety of 
prokaryotes contains LuxS gene homolog, which 
encodes for the protein S-ribosylhomocysteinelyase 
(LuxS). This protein is responsible for production of the 
quorum-sensing molecule AI-2 and has been implicated 
in a variety of functions, such as flagellar motility, 
metabolic regulation, toxin production, and even in 
pathogenicity4. LuxS in Staphylococcus epidermidis is 
functional and LuxS-dependent gene regulation 
represses biofilm formation in vitro and pathogen 
success during biofilm-associated infection. Although 
regulating different biofilm factors, the two QS systems 
of Staphylococcus sp., agr and LuxS, have similar 
effects on the biofilm mode of growth5. 
The ultimate goal of molecular docking can be 
defined as the prediction of the donor-acceptor complex 
structure, where the receptor is usually a protein and the 
binder is a small natural or synthetic molecule, peptides, 
or proteins. In docking, the search algorithm explores 
different positions for the ligand in the receptor’s active 
site, using its translational, rotational, and 
conformational degrees of freedom6. There are two key 
points in any docking program: The search for the “best” 
conformation resulting from the formation of the 
protein-ligand complex and the calculation of free 
energy for its association7.  
The need for a rapid search for small molecules that 
may bind to targets of biological interest is of crucial 
importance in the drug discovery process. One way of 
achieving this is the in silico or virtual screening (VS) of 
huge compound collections to identify a subset of 
compounds that contains relatively many hits against the 
target, compared to a random selection from the 
collection. The compounds that are virtually screened 
can stem from corporate or commercial compound 
collections, or from virtual compound libraries. If a 
three-dimensional (3D) structure of the target is 
available, a commonly used technique is structure-based 
virtual screening (SBVS)8. 
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The construction of reliable scoring functions is fast 
enough to evaluate hundreds or thousands of ligands in a 
few minutes. This has led to the development of a large 
number of functions that make use of approximations 
for assessment of the affinity constant of a 
receptor-ligand complex9. The aim of computer 
simulations of molecular systems is to compute 
macroscopic behavior from microscopic interactions.10 
The present study aims at characterization of virulent 
protein-LuxS through 3D structure prediction and 
validation, molecular docking, and dynamic simulation, 
and VS analysis in Staphylococcus hominis by 
Maybridge and Binding databases against LuxS protein. 
 
Materials and Methods 
 
Template selection of LuxS protein 
The amino acid sequence of LuxS protein from S. 
hominis was obtained in FASTA format from the 
UniProtKB database (accession number C2LXE0). 
The retrieved protein sequence was submitted to a 
Blastp search against the Protein Data Bank (PDB) 
for getting the best structural homology of the protein 
LuxS. From the results based on the high sequence 
identity and query coverage, the protein structure with 
PDB ID: 1J6X was selected as a template.  
 
Target-template alignment 
The sequence data of the target and template were 
subjected to sequence alignment which was 
performed by CLUSTAL OMEGA. A global dynamic 
programming algorithm was used to construct an 
alignment for full length of the sequences. In the 
CLUSTAL OMEGA program, the pairwise distances 
are used to locally adjust the gap opening calculated 
using a fast approximate method. These multiple 
sequence alignments provide structural and functional 
information11. 
 
Homology modeling of LuxS 
Modeller 9.17 program (http://www.salilab.org/ 
modeller/) was employed to generate the initial 3D 
models of LuxS. It generates 3D models by optimization 
of molecular probability density functions. The 
optimization process consists of applying the variable 
target function as well as conjugated gradients and 
molecular dynamics (MD) with simulated annealing. 
The final homology model was selected on the basis of 
DOPE score and GA341 score. 
 
Model validation of LuxS protein 3D structure  
The 3D models of LuxS protein were verified using 
PROCHECK program of Structural Analysis and 
Verification Server (SAVS). The overall stereochemical 
quality of the protein was assessed by Ramachandran 
plot analysis. The quality of the modeled protein LuxS 
was also validated by the ProSA server, available at 
https://prosa.services.came.sbg.ac.at/prosa.php. The 
ProSA provided the Z-score of the LuxS model. The 
ProSA program was employed to evaluate the quality of 
consistency between the native fold and the sequence 
and examine the energy of residue-residue interactions 
using a distance-based pair potential. The energy was 
transformed to a score called Z-score. Residues  
with negative Z-score indicate reasonable  
side-chain interactions. The ESPript program 
(http://espript.ibcp.fr/ESPript) was used to generate 
figures of aligned sequences with secondary structure 
information of the modeled protein LuxS. The program 
is written in Fortran and can be executed locally on 
Linux or Unix machines or on a web server via a CGI 
interface12. 
 
Virtual screening 
Virtual screeing (VS) was performed to identify 
possible lead compounds from the Maybridge 
HitFinder™ database and the binding database. The 
ligand-based VS of inhibitor compound database with 
prepared protein was performed with the OPLS3 force 
field using the virtual screening workflow (VSW) 
module of the Schrodinger suite. The Maybridge Hit 
Finder™ sets are structural representatives of large 
non-redundant chemical libraries. This collection 
includes 14,400 compounds that represent the drug-like 
diversity of the Maybridge screening collection 
(~56,000 compounds). The Maybridge HitFinder™ set 
was obtained from http://www.maybridge.com. The 
ligand files were prepared for docking using 
Schrodinger LigPrep software. In addition to the 
generation of energy-minimized 3D structures, 
Schrodinger LigPrep was also used for addition of 
hydrogen and desalting of metal ions13. The binding 
database (http://www.bindingdb.org) is a publicly 
accessible database currently containing 20,000 
experimentally determined binding affinities of 
protein-ligand complexes for 110 protein targets 
including isoforms and mutational variants and 11,000 
small molecule ligands. The data were extracted from 
scientific literature, data collection focusing on proteins 
that are drug-targets or candidate drug-targets, for 
which structural data are present in the PDB. The data 
in the binding DB are linked to structural data in the 
PDB via PDB IDs. Also the chemical and sequence 
searches were referred to the literature in PubMed14. A 
total of 47 compounds were identified. 
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Molecular docking 
Twenty-eight marine compounds were downloaded 
from Pubchem in the SDF file format. All the 
compounds were prepared by using the LigPrep module 
in Schrodinger 2015. The main objective of using 
LigPrep was to obtain low-energy 3D structures of the 
set of ligands in the library, for use in further 
computational studies. The OPLS3 force field was 
utilized to optimize the geometry and minimize the 
energy. Force field parameters were assigned to the 
ligand atoms using default treatment for possible 
tautomers, ionization at a selected pH range (7 ± 2 by 
default), and ring conformations (1 ring conformer by 
default). The co-crystallized ligand was considered as 
the reference molecule and a grid-enclosing box was 
centered at the co-crystallized ligand. The grid box was 
generated around the ligand binding site of the screened 
targets. The position of grid box was set as XYZ axis 
with radius 2.0 Å and the van der Waals (VDW) radii of 
the receptor atoms as 1.00 Å with a partial charge cutoff 
of 0.25 Å to soften the potential for the nonpolar part of 
the receptor. The LuxS was docked onto the ligand-
binding site of the screened targets using Glide extra-
precision (XP) docking (Glide, version 6.6, Schrödinger, 
LLC, New York, NY, 2015). Glide score (a modified 
and extended version of the empirically base function), 
Glide energy (modified Coulomb–VDW interaction 
energy), hydrogen bond interaction, and hydrophobic 
interactions were considered to investigate the 
therapeutic effect of LuxS15.  
 
Molecular dynamics 
MD simulations were performed using the program 
Desmond. The initial coordinates for the MD 
calculations were taken from the modeled protein. The 
OPLS-2005 force field was used to model all amino acid 
interactions in the protein. Using System Builder, a 10 Å 
orthorhombic box with periodic boundary condition was 
constructed with a Four-Point Transferable Inter-
molecular Potential (TIP4P) water model. A short 
energy minimization was performed via the steepest 
descent method, followed by a limited memory variation 
of the Broyden-Fletcher-Goldfarb-Shanno (LBFGS) 
algorithm. Salt concentrations of 0.15 M of Na+ or Cl− 
molecules were added to balance the net charge of the 
system. Before continuing with the production phase of 
MD simulations, the system was minimized with the 
default parameter set. The covalent bonds involving H 
atoms were constrained using the SHAKE algorithm and 
Particle Mesh Ewald (PME) method for electrostatics. 
The temperature was maintained at 300 K using the 
Nose-Hoover coupling algorithm and pressure of 1 bar 
was maintained through the Martyna-Tobias-Klein 
method. During MD simulation, all protein-ligand 
complexes were simulated for 10 ns. Energy and atomic 
coordinate trajectories were recorded every 3 ns. The 
root mean square deviation (RMSD), root mean square 
fluctuation (RMSF), and protein-ligand contacts in each 
trajectory were analyzed with respect to a time scale. 
The plots were graphically analyzed using OriginPro. 
 
Results and Discussion 
 
Homology modeling 
The homology modeling is to select an appropriate 
template structure for constructing the target model. The 
sequence encoding for LuxS protein with UniProtKB 
ID: C2LXE0 was retrieved from the UniProt database. 
A Blastp search against PDB proteins confirmed that 
several PDB structures could serve as the potential 
template for building the LuxS model. LuxS has 65% 
sequence identity and 84% sequence similarity with the 
crystal structure PDB ID: 1J6X. Sequence data of target 
and template were aligned using the program 
CLUSTALW. The alignment between target and 
template sequence contains gaps. Here the pairwise 
sequence alignment between the target (C2LXE0) and 
template (1J6X) from residues 1 to 156 were aligned 
using CLUSTAL OMEGA. Among the available 
potential templates, the crystal structure of 1J6X was 
eventually selected as the template structure to construct 
the LuxS model (Fig. 1) in terms of the earlier criteria. 
The Vc-HlyU has identified Blast search for the 
  
Fig. 1 — Ribbon schematic representation of modeled LuxS protein.  
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proteins with similar sequence and known 3D 
structure using the 108-residue-long Vc-HlyU 
sequence (SWISS-PROT: P52695)15. The modeling 
approaches of the proteins CadC, CzrA from S. 
aureus pI258, and SmtB from Synechococcus sp have 
been previously documented16. 
 
Model validation by SAVS 
The Modeller-generated models were statistically 
analyzed by SAVS. The structures submitted were 
validated and the final protein structures selected after 
analysis in SAVS. Figure 2 shows the Ramachandran 
plot of the modeled protein LuxS. In the 
Ramachandran plot analysis, the residues were 
classified according to their regions in the quadrangle. 
Becker et al.17 reported that the stereochemistry of the 
four models of human p-glycoprotein was assessed 
with PROCHECK. The Ramachandran plots showed a 
high percentage of the residues in the allowed regions: 
99.7% and 98.3% for the nucleotide-bound models 
built with the SAV1866 and MsbA Salmonella 
typhimurium structures18. 
In the present study also, the stereochemical quality 
of the model was assessed with the PROCHECK 
program which predicted the model using the 
Ramachandran plot that 100% of the non-glycine 
residues and non-proline residues of the model had 
dihedral angles (the angle between two intersecting 
planes) in the most favored and additionally allowed 
region. No residues were found in disallowed regions 
 
  
Fig. 2 — Ramachandran plot of the modeled protein LuxS 
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and the plot value was found to be 92.1% with 129 
residues in the favored region. Such a percentage 
distribution determined by Ramachandran plot shows 
that the predicted model is quite satisfactory.  
 
ProSA 
The ProSA analysis showed that the Z-score in the 
LuxS model was negative in most residues. The Z-
score of ProSA indicates overall model quality and 
measures the deviation of the total energy of the 
structure with respect to an energy distribution derived 
from random conformations. The Z-scores outside a 
range characteristic for native proteins indicate 
erroneous structures. To facilitate interpretation of the 
Z-score of the specified protein, its particular value is 
displayed in a plot that contains the Z-scores of the 
modeled protein19. In the present study, very few 
residues display negative interaction energies. It can be 
seen from Figure 3 that the overall results of LuxS 
were quite similar to those of the templates.  
 
ESpript 
ESpript was used in this study and the output 
obtained for the modeled protein LuxS is shown in 
Figure 4. Secondary structure elements are presented in 
the top panel: Helices are presented with squiggles, beta 
strands with arrows, and turns with TT letters. Strictly 
conserved residues are highlighted in red and partially 
conserved residues in yellow boxes. Sequence alignment 
between LdDCP (accession no. AAV80217) and 
EcDCP (accession no. P24171) sequences were 
produced by CLUSTALW. Alignment length: 
 
 
Fig. 3 — ProSA Z-score with respect to residue (window size=40). The scores of C2LXE0 and 1J6X are shown in dark green solid lines 
and light green solid lines, separately. 
 
  
Fig. 4 — Secondary structure elements of the modeled protein LuxS 
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conserved regions are represented by black boxes. The 
secondary structure of EcDCP is demonstrated with 
arrows for β-sheet and spiral for α-helices. Zinc binding 
motif is represented by the asterisk20.  
 
VS with Maybridge and binding database 
Computer-based strategies for structure-based drug 
discovery presents a valuable alternative to the costly 
and time-consuming process of random screening. In 
the present study, two different VS databases were 
used. This was done to ensure that the ligands 
shortlisted were actually docking into the binding site 
of interest13. On the basis of these criteria, the best 
five compounds from each of the binding and 
Maybridge databases were selected. The compounds 
selected from Maybridge database, namely, CID-
9017, CID-6856, CID-2988, CID-9269, and CID-
9270 were docked with the lowest binding energy of -
9.820, -8.816, -8.567, -8.421, and -8.932, respectively 
and those from the Binding database, namely, CID-
11446, CID-30686, CID-19559, CID-27386, and 
CID-347272 were docked with the lowest binding 
energy of -9.647, -9.114, -9.106, -8.988, and -8.897, 
respectively.  
VSW uses Glide docking to rank the best 
compound which utilizes the scoring functions, high 
throughput virtual screening (HTVS), standard 
precision (SP), and XP. While HTVS and SP modes 
are used for a large set of ligands, XP docking is more 
accurate than these two methods. It uses the ligand 
poses that have a high score from SP docking. The XP 
GlideScore scoring function was used to order the 
best ranked compounds and specific interactions for 
example pi-cation and pi-pi stacking were analyzed 
using the XP visualizer in the Glide module21.  
In this study, five compounds were selected from 
the Maybridge and binding databases on the basis of 
best docking score and Glide energy. The 3D (left 
panel) and 2D (right panels) diagrams in Figure 5 
show protein-ligand interactions between LuxS and 
the five hit compounds. The hit compounds, the 
amino acid residue involved in the interaction with 
the hit compound, and other residues around the 
binding pocket were represented in stick and line 
forms, respectively. The hydrogen bond interactions 
between the compounds and the binding residues are 
shown as violet dashed lines. 
 
Molecular docking 
The geometries of the compounds were optimized by 
adding hydrogen and eliminating unwanted structures 
using the LigPrep module, and a database of chemical 
compounds was created using the Schrodinger suite; 
docking was performed using Glide. The 28 marine 
compounds, namely, camphor (CID-2537), baicalin 
(CID-64982), 4-hydroxy benzamide (CID-65052), 
cyanidin (CID-68247), aquayamycin (CID-73441), 
griseoluteic acid (CID-120266), vibrioferrin (CID-
197680), cichoriin (CID-442101), acacetin (CID-
5280442), apigenin (CID-5280443), baicalein (CID-
5281605), daidzein (CID-5281708), prodigiosin 
(CID-5351169), fluvibactin (CID-5487127), 
anguibactin (CID-5487148), vulnibactin (CID-
5487539), vibriobactin (CID-5487798), aerobactin 
(CID-123762), andrimid (CID-6439264), 
cycloprodigiosin (CID-6439795), magnesidin (CID-
6443586), vibrindole A (CID-6452189), holomycin 
(CID-10262683), moiramide B (CID-11744644), 
vanchrobactin (CID-16658367), chembl 220619 
(CID-23246249), trivanchrobactin (CID-46849168), 
and divanchrobactin (CID-46849169) were prepared 
separately by LigPrep and were docked into the 
binding pockets of the LuxS protein.  
 
Molecular docking simulations of the 28 
compounds active against the protein resulted in a few 
best compounds that were evaluated on the basis of 
their binding compatibility [docked energy 
(kcal/mol)] with the receptor. The final G-scores were 
analyzed on the basis of the conformation at which 
the ligands formed hydrogen bonds with at least one 
of the active-site amino acid residues of the 
corresponding 3D structure of the modeled protein 
with optimal binding affinity. The Glide scores and 
energies, including the VDW and electrostatic 
energies, were calculated for all the ligands against 
LuxS. On analyzing the docking score and the Glide 
energy, it was found that the ligands vibriobactin  
(-10.232, -65.556) and aerobactin (-10.337, -62.918) 
possessed better scores than the other compounds. 
Kirubakaran et al.22 reported the in silico studies on 
marine actinomycetes as potential inhibitors for 
Glioblastoma multiforme (GBM). In this study, three 
proteins were considered to be the potential 
therapeutic targets for GBM. Among these, EphA2 
was reported to be overexpressed in ~90% of GBM22. 
In the present case, in silico docking studies show that 
the marine compound aerobactin has an inhibitory 
effect on LuxS protein. MD simulation was 
performed to check the stability of the protein-ligand 
complex. The results show that the compound 
aerobactin is a potential inhibitor of LuxS protein. 
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